Legal & General Group Plc - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,000
-33.3%
4,593
-13.8%
0.00%
Q1 2022$6,000
-64.7%
5,3280.0%0.00%
Q4 2021$17,000
-29.2%
5,3280.0%0.00%
Q3 2021$24,000
-17.2%
5,3280.0%0.00%
Q2 2021$29,000
-25.6%
5,328
+3.5%
0.00%
Q1 2021$39,000
-79.4%
5,148
-70.4%
0.00%
Q4 2020$189,000
+320.0%
17,405
+238.7%
0.00%
Q3 2020$45,000
-38.4%
5,139
-24.9%
0.00%
Q2 2020$73,000
+135.5%
6,844
+19.8%
0.00%
Q1 2020$31,000
-36.7%
5,713
-20.2%
0.00%
Q4 2019$49,000
-18.3%
7,158
+23.6%
0.00%
Q3 2019$60,000
+30.4%
5,7910.0%0.00%
Q2 2019$46,000
+15.0%
5,791
+31.0%
0.00%
Q1 2019$40,000
+100.0%
4,420
+21.3%
0.00%
Q4 2018$20,000
-53.5%
3,6450.0%0.00%
Q3 2018$43,000
+16.2%
3,6450.0%0.00%
Q2 2018$37,000
+12.1%
3,645
+41.6%
0.00%
Q1 2018$33,000
-5.7%
2,574
-28.6%
0.00%
Q4 2017$35,000
-23.9%
3,604
+15.8%
0.00%
Q3 2017$46,000
+27.8%
3,112
+42.3%
0.00%
Q2 2017$36,000
+300.0%
2,187
+275.1%
0.00%
Q1 2017$9,000
+28.6%
5830.0%0.00%
Q4 2016$7,0005830.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,139,895$23,486,0004.50%
Samsara BioCapital, LLC 2,189,199$14,769,0002.72%
Bain Capital Life Sciences Investors, LLC 5,785,036$43,272,0002.45%
Omega Fund Management, LLC 1,562,500$11,688,0001.11%
Flagship Pioneering Inc. 2,938,494$21,980,0000.35%
EcoR1 Capital, LLC 1,000,000$7,480,0000.33%
Altium Capital Management LP 126,702$948,0000.26%
Nikko Asset Management Americas, Inc. 5,042,009$37,714,0000.18%
Artal Group S.A. 1,025,000$7,667,0000.14%
Orbimed Advisors 1,837,500$13,745,0000.13%
View complete list of SYROS PHARMACEUTICALS INC shareholders